LambdaTest Inc d/b/a TestMu
8.4.2026 17:00:00 CEST | Globenewswire | Press release
TestMu AI Announces GitHub App Integration for KaneAI, enabling End‑to‑End AI‑Powered Test Validation Directly in Pull Requests
TestMu AI Announces GitHub App Integration for KaneAI, enabling End‑to‑End AI‑Powered Test Validation Directly in Pull Requests
TestMu AI Launches GitHub App Integration for Seamless AI-Powered Test Validation in Pull Requests
San Francisco, CA, April 08, 2026 (GLOBE NEWSWIRE) -- TestMu AI (formerly LambdaTest), the world’s first full-stack Agentic Quality Engineering platform, today unveiled its TestMu AI Cloud GitHub App, an integrated workflow that brings KaneAI — TestMu AI’s autonomous AI testing agent directly into the GitHub pull request lifecycle. This integration enables developers to trigger intelligent test generation, execution, and reporting with a single comment, fundamentally transforming the way teams validate code changes.
In modern software delivery, validating changes often involves manual coordination between development and QA teams. TestMu AI’s GitHub App eliminates this friction by automating context‑aware testing inside the GitHub user experience. Once the app is installed from the GitHub Marketplace and enabled for specific repositories, KaneAI delivers a complete testing pipeline, from code analysis to AI‑authored tests, scalable execution, and AI‑driven reporting — without forcing developers to leave the GitHub interface.
Triggering Intelligent Testing with a Single Comment
To initiate a full validation cycle, developers simply add a comment such as: @KaneAI Validate this PR, or @LambdaTest Validate this PR. KaneAI then:
- Analyzes the Code & Context: Reading the diff, PR title, description, README.md, and optional agent.md for project context.
- Generates Intelligent Tests: AI‑driven creation of end‑to‑end test cases, complete with assertions that reflect both technical changes and business logic.
- Smartly Leverages Existing Test Inventory: Identifies semantically similar tests already present in TestMu AI’s Test Manager and adds them to the validation run.
- Executes at Scale: Runs tests in parallel across browsers, devices, and platforms on TestMu AI’s HyperExecute infrastructure.
- Delivers Real‑Time Feedback: Posts dynamic progress tracking in the PR and final results with AI‑powered root cause analysis (RCA) and actionable recommendations — all without requiring context switching.
“Developers should ship confidence, not just code,” said Mayank Bhola, Co‑Founder and Head of Product at TestMu AI. “The GitHub App integration embodies that philosophy by integrating AI‑native testing into the pull request workflow itself, empowering teams to validate changes faster, with greater coverage and deeper insights.”
Enterprise‑Grade Quality with Seamless Developer Experience
The GitHub App offers a range of benefits designed to accelerate delivery and strengthen confidence across teams:
- Native Workflow Integration: Testing is triggered and tracked entirely inside GitHub, avoiding context switching and operational overhead.
- AI‑Native Test Case Generation: KaneAI’s analysis produces test cases that directly reflect code changes and business logic rather than generic boilerplate.
- HyperExecute Execution: Leverages TestMu AI’s HyperExecute cloud to run tests in parallel, delivering results in minutes.
- AI Root Cause Analysis: Failure diagnostics go beyond pass/fail status, surfacing actionable root causes with recommended remediation steps.
- Unified Test Management: All generated tests sync with TestMu AI Test Manager for visibility, traceability, and long‑term QA governance.
Easy Installation and Configuration
Getting started is straightforward: install the TestMu AI Cloud GitHub App from the GitHub Marketplace, configure repository access (organization‑wide or selectively), and add a .lambdatest/config.yaml file in the project repository to connect it with the user’s TestMu AI Test Manager environment. KaneAI uses this configuration, along with project metadata such as the repository’s README.md, to improve test quality and relevance.
The TestMu AI Cloud GitHub App is now available to organizations using the TestMu AI platform and KaneAI. Installation is accessible via the GitHub Marketplace, and teams can begin validating pull requests within minutes: https://github.com/apps/lambdatest-ai-cloud
About TestMu AI
TestMu AI (Formerly LambdaTest) is a Full-Stack Agentic AI Quality Engineering platform that empowers teams to test intelligently and ship faster. Engineered for scale, it offers end-to-end AI agents to plan, author, execute, and analyze software quality. AI-native by design, the platform enables testing of web, mobile, and enterprise applications at any scale across real devices, real browsers, and custom real-world environments.
For more information, visit https://www.testmuai.com/
Media Contact: Nikhil Saxena Press and Media Manager 9870981968 nikhils@testmuai.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
Junshi Biosciences24.10.2026 05:30:32 CEST | Press release
Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom